Search research articles
Contact Us
Filters
Showing results (31-40 of 50) with videos related to
Page
of 5
Sort By:
Current Oncology (Toronto, Ont.)
|
December 27, 2024
Prevalence and Significance of Incidental PET/CT Findings of Cancer Detected in Patients Evaluated for Their Primary Hematologic Malignancy: A Systematic Review
Jessie Luo, Nizar J Bahlis, Denise Chan, et al.
Canadian Journal of Kidney Health and Disease
|
February 24, 2025
Clinical and Pathological Characteristics of Non-AL Amyloidosis MGRS: A Single-Center Experience Over 10 Years
Chunpeng Nie, Holly Lee, Kim Cheema, et al.
Leukemia & Lymphoma
|
August 26, 2021
Excess of deaths for patients with plasma cell proliferative disorders as a result of the COVID-19 pandemic
Tom Dunne, Douglas Stewart, Holly Lee, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 9, 2020
Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) for the Treatment of Newly Diagnosed AL Amyloidosis: Impact of Response on Survival Outcomes
Carolina Diaz-Pallares, Holly Lee, Joanne Luider, et al.
Environment International
|
February 25, 2014
Cooking fish is not effective in reducing exposure to perfluoroalkyl and polyfluoroalkyl substances
Satyendra P Bhavsar, Xianming Zhang, Rui Guo, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion
|
September 8, 2021
Impact of COVID-19 on the Diagnosis and Management of Multiple Myeloma: Experience from a Canadian Center
Victor H Jimenez-Zepeda, Patrick Yau, Douglas Stewart, et al.
Biorxiv : the Preprint Server for Biology
|
June 3, 2024
Timing antigenic escape in multiple myeloma treated with T-cell redirecting immunotherapies
Marios Papadimitriou, Sungwoo Ahn, Benjamin Diamond, et al.
British Journal of Haematology
|
February 22, 2020
Anti-myeloma potential of ruxolitinib in co-existing JAK2V617F-positive smouldering myeloma and polycythaemia vera
Holly Lee, Sylvia McCulloch, Etienne Mahe, et al.
Blood
|
September 20, 2023
Integrated epigenetic and transcriptional single-cell analysis of t(11;14) multiple myeloma and its BCL2 dependency
Noémie Leblay, Sungwoo Ahn, Rémi Tilmont, et al.
Blood Cancer Discovery
|
September 4, 2025
Timing genomic antigen loss in multiple myeloma treated with T-cell redirecting immunotherapies
Marios Papadimitriou, Sungwoo Ahn, Benjamin T Diamond, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 50) with videos related to
Sort By:
Page
of 5
Current Oncology (Toronto, Ont.)
|
December 27, 2024
Prevalence and Significance of Incidental PET/CT Findings of Cancer Detected in Patients Evaluated for Their Primary Hematologic Malignancy: A Systematic Review
Jessie Luo, Nizar J Bahlis, Denise Chan, et al.
Canadian Journal of Kidney Health and Disease
|
February 24, 2025
Clinical and Pathological Characteristics of Non-AL Amyloidosis MGRS: A Single-Center Experience Over 10 Years
Chunpeng Nie, Holly Lee, Kim Cheema, et al.
Leukemia & Lymphoma
|
August 26, 2021
Excess of deaths for patients with plasma cell proliferative disorders as a result of the COVID-19 pandemic
Tom Dunne, Douglas Stewart, Holly Lee, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 9, 2020
Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) for the Treatment of Newly Diagnosed AL Amyloidosis: Impact of Response on Survival Outcomes
Carolina Diaz-Pallares, Holly Lee, Joanne Luider, et al.
Environment International
|
February 25, 2014
Cooking fish is not effective in reducing exposure to perfluoroalkyl and polyfluoroalkyl substances
Satyendra P Bhavsar, Xianming Zhang, Rui Guo, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion
|
September 8, 2021
Impact of COVID-19 on the Diagnosis and Management of Multiple Myeloma: Experience from a Canadian Center
Victor H Jimenez-Zepeda, Patrick Yau, Douglas Stewart, et al.
Biorxiv : the Preprint Server for Biology
|
June 3, 2024
Timing antigenic escape in multiple myeloma treated with T-cell redirecting immunotherapies
Marios Papadimitriou, Sungwoo Ahn, Benjamin Diamond, et al.
British Journal of Haematology
|
February 22, 2020
Anti-myeloma potential of ruxolitinib in co-existing JAK2V617F-positive smouldering myeloma and polycythaemia vera
Holly Lee, Sylvia McCulloch, Etienne Mahe, et al.
Blood
|
September 20, 2023
Integrated epigenetic and transcriptional single-cell analysis of t(11;14) multiple myeloma and its BCL2 dependency
Noémie Leblay, Sungwoo Ahn, Rémi Tilmont, et al.
Blood Cancer Discovery
|
September 4, 2025
Timing genomic antigen loss in multiple myeloma treated with T-cell redirecting immunotherapies
Marios Papadimitriou, Sungwoo Ahn, Benjamin T Diamond, et al.
Page
of 5